These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

580 related items for PubMed ID: 19247847

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Patterns of psoriatic arthritis in Orientals.
    Thumboo J, Tham SN, Tay YK, Chee T, Mow B, Chia HP, Boey ML.
    J Rheumatol; 1997 Oct; 24(10):1949-53. PubMed ID: 9330937
    [Abstract] [Full Text] [Related]

  • 24. Psoriatic arthritis.
    Rajendran CP, Ledge SG, Rani KP, Madhavan R.
    J Assoc Physicians India; 2003 Nov; 51():1065-8. PubMed ID: 15260390
    [Abstract] [Full Text] [Related]

  • 25. Remission in psoriatic arthritis.
    Gladman DD, Hing EN, Schentag CT, Cook RJ.
    J Rheumatol; 2001 May; 28(5):1045-8. PubMed ID: 11361187
    [Abstract] [Full Text] [Related]

  • 26. Psoriatic arthritis in Reykjavik, Iceland: prevalence, demographics, and disease course.
    Love TJ, Gudbjornsson B, Gudjonsson JE, Valdimarsson H.
    J Rheumatol; 2007 Oct; 34(10):2082-8. PubMed ID: 17696270
    [Abstract] [Full Text] [Related]

  • 27. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
    Antoni CE, Kavanaugh A, Kirkham B, Tutuncu Z, Burmester GR, Schneider U, Furst DE, Molitor J, Keystone E, Gladman D, Manger B, Wassenberg S, Weier R, Wallace DJ, Weisman MH, Kalden JR, Smolen J.
    Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699
    [Abstract] [Full Text] [Related]

  • 28. Improving recognition of psoriatic arthritis.
    Conaghan PG, Coates LC.
    Practitioner; 2009 Dec; 253(1724):15-8, 2-3. PubMed ID: 20120827
    [Abstract] [Full Text] [Related]

  • 29. Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: a nationwide cohort study.
    Chen YJ, Chang YT, Shen JL, Chen TT, Wang CB, Chen CM, Wu CY.
    Arthritis Rheum; 2012 Jun; 64(6):1879-87. PubMed ID: 22161801
    [Abstract] [Full Text] [Related]

  • 30. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA).
    Theander E, Husmark T, Alenius GM, Larsson PT, Teleman A, Geijer M, Lindqvist UR.
    Ann Rheum Dis; 2014 Feb; 73(2):407-13. PubMed ID: 23355078
    [Abstract] [Full Text] [Related]

  • 31. [Prognostic factors in the evolution of psoriatic arthritis].
    Ros Expósito S, Rodríguez Moreno J, Gómez Vaquero C, Campoy Reolid E, Roig Escofet D.
    Med Clin (Barc); 1997 Feb 01; 108(4):133-5. PubMed ID: 9162782
    [Abstract] [Full Text] [Related]

  • 32. Extended report: nail disease in psoriatic arthritis--clinically important, potentially treatable and often overlooked.
    Williamson L, Dalbeth N, Dockerty JL, Gee BC, Weatherall R, Wordsworth BP.
    Rheumatology (Oxford); 2004 Jun 01; 43(6):790-4. PubMed ID: 15113998
    [Abstract] [Full Text] [Related]

  • 33. Risk factors for the development of psoriatic arthritis: a population based nested case control study.
    Thumboo J, Uramoto K, Shbeeb MI, O'Fallon WM, Crowson CS, Gibson LE, Michet CJ, Gabriel SE.
    J Rheumatol; 2002 Apr 01; 29(4):757-62. PubMed ID: 11950018
    [Abstract] [Full Text] [Related]

  • 34. Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register.
    Kristensen LE, Gülfe A, Saxne T, Geborek P.
    Ann Rheum Dis; 2008 Mar 01; 67(3):364-9. PubMed ID: 17644547
    [Abstract] [Full Text] [Related]

  • 35. HLA-C locus alleles may modulate the clinical expression of psoriatic arthritis.
    Queiro R, Gonzalez S, López-Larrea C, Alperi M, Sarasqueta C, Riestra JL, Ballina J.
    Arthritis Res Ther; 2006 Mar 01; 8(6):R185. PubMed ID: 17166285
    [Abstract] [Full Text] [Related]

  • 36. Obesity in early adulthood as a risk factor for psoriatic arthritis.
    Soltani-Arabshahi R, Wong B, Feng BJ, Goldgar DE, Duffin KC, Krueger GG.
    Arch Dermatol; 2010 Jul 01; 146(7):721-6. PubMed ID: 20644032
    [Abstract] [Full Text] [Related]

  • 37. Utility-based outcomes made easy: the number needed per quality-adjusted life year gained. An observational cohort study of tumor necrosis factor blockade in inflammatory arthritis from Southern Sweden.
    Gülfe A, Kristensen LE, Saxne T, Jacobsson LT, Petersson IF, Geborek P.
    Arthritis Care Res (Hoboken); 2010 Oct 01; 62(10):1399-406. PubMed ID: 20506121
    [Abstract] [Full Text] [Related]

  • 38. Incidence of clinically important 10-year health status and disease activity levels in population-based cohorts with rheumatoid arthritis.
    Odegård S, Kvien TK, Uhlig T.
    J Rheumatol; 2008 Jan 01; 35(1):54-60. PubMed ID: 18050381
    [Abstract] [Full Text] [Related]

  • 39. Incidence of arthritis in a prospective cohort of psoriasis patients.
    Eder L, Chandran V, Shen H, Cook RJ, Shanmugarajah S, Rosen CF, Gladman DD.
    Arthritis Care Res (Hoboken); 2011 Apr 01; 63(4):619-22. PubMed ID: 21452273
    [Abstract] [Full Text] [Related]

  • 40. Clinical and genetic aspects of psoriatic arthritis "sine psoriasis".
    Scarpa R, Cosentini E, Manguso F, Oriente A, Peluso R, Atteno M, Ayala F, D'Arienzo A, Oriente P.
    J Rheumatol; 2003 Dec 01; 30(12):2638-40. PubMed ID: 14719207
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.